Angiotensin converting enzyme inhibitor therapy in children with Alport syndrome: effect on urinary albumin, TGF-β, and nitrite excretion

BACKGROUND: Angiotensin converting enzyme inhibitors are routinely prescribed to patients with chronic kidney disease because of their known renoprotective effects. We evaluated the effect of short-term therapy with the angiotensin converting enzyme inhibitor, enalapril, in early Alport syndrome, de...

Descripción completa

Detalles Bibliográficos
Autores principales: Adler, Liora, Mathew, Roy, Futterweit, Stephen, Frank, Rachel, Gauthier, Bernard G, Kashtan, Clifford E, Trachtman, Howard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC65703/
https://www.ncbi.nlm.nih.gov/pubmed/11869456
http://dx.doi.org/10.1186/1471-2369-3-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC65703/
https://www.ncbi.nlm.nih.gov/pubmed/11869456
http://dx.doi.org/10.1186/1471-2369-3-2

Ejemplares similares